Back to the complete issue
Tuesday, 18 January 2022

Rameda to bring Merck anti-covid pill to Egypt this quarter

Rameda to launch generic form of Merck’s covid pill: Rameda Pharma will begin selling its own generic version of Merck’s oral antiviral covid-19 med, Molnupiravir Rameda, before the end of 1Q2022, the company announced in an EGX disclosure (pdf). The company has begun manufacturing the pill after receiving authorization from the EDA, the national meds regulator. Molnupiravir Rameda will retail at EGP 625 per 40 capsules with an initial dose of 200 mg, with an eye to launch other, stronger versions of the pill “in due course,” the company said.

A total of five Egyptian companies are lining up to produce new covid meds and are waiting on the approval from the EDA, Health Ministry spokesperson Hossam Abdel Ghaffar said on Salat Tahrir yesterday (watch, runtime: 1:03:31).

The Health Ministry reported 1,232 new covid-19 infections yesterday, up from 1,197 the day before. Egypt has now disclosed a total of 401,308 confirmed cases of covid-19. The ministry also reported 31 new deaths, bringing the country’s total death toll to 22,179.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.